Tiny implants offer new hope for glaucoma patients facing major surgery
NCT ID NCT07228221
Summary
This study is testing whether two small devices implanted in the eye can safely lower eye pressure in people with moderate-to-severe glaucoma that isn't controlled by eye drops. The devices (iStent infinite and iDose TR) are designed to be a less invasive alternative to traditional glaucoma surgery. Researchers will measure how much they reduce eye pressure and the need for daily medications over 12 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wills Eye Hosital Glaucoma Dept.
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.